Provided by Tiger Trade Technology Pte. Ltd.

Phasebio Pharmaceuticals Inc

0.0701
0.0000
Volume:- -
Turnover:- -
Market Cap:3.50M
PE:-0.03
High:0.0701
Open:0.0701
Low:0.0701
Close:0.0701
52wk High:1.38
52wk Low:0.0665
Shares:49.86M
Float Shares:34.41M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1189
EPS(LYR):-2.9844
ROE:-3091.02%
ROA:-106.07%
PB:-0.03
PE(LYR):-0.02

Loading ...

Mar 30, 2020

Major Issues Report

Current report, items 2.02, 7.01, and 9.01
Mar 20, 2020

Major Issues Report

Current report, items 1.01 and 2.03
Mar 04, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Major Issues Report

Current report, items 5.02, 7.01, and 9.01
Feb 11, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Feb 04, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Jan 27, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 17, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 13, 2020

Major Issues Report

Current report, items 1.01, 2.01, 3.02, 7.01, and 9.01
Jan 10, 2020

Major Issues Report

Current report, items 1.01, 7.01, and 9.01
Jan 06, 2020

Correspondence

[Cover]Correspondence
Nov 14, 2019

Major Issues Report

Current report, items 2.02, 7.01, and 9.01
Nov 14, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Oct 15, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Sep 24, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Aug 14, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 14, 2019

Major Issues Report

Current report, items 7.01, 8.01, and 9.01
Aug 13, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Jul 29, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership